Edition:
United Kingdom

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.03USD
8:59pm GMT
Change (% chg)

$-0.88 (-4.65%)
Prev Close
$18.91
Open
$19.00
Day's High
$19.13
Day's Low
$17.99
Volume
59,040
Avg. Vol
--
52-wk High
$25.33
52-wk Low
$12.51

Latest Key Developments (Source: Significant Developments)

Apellis Finalizes Late Stage Trial Plans For Eye Disease Treatment
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Apellis Pharmaceuticals Inc ::APELLIS FINALIZES PHASE 3 CLINICAL TRIAL PLANS FOR GEOGRAPHIC ATROPHY TREATMENT WITH APL-2.APELLIS PHARMACEUTICALS INC - PHASE 3 PROGRAM EVALUATING APL-2 PLANNED TO BEGIN IN SECOND HALF OF 2018.APELLIS PHARMACEUTICALS - PHASE 3 PROGRAM TO CONSIST OF TWO IDENTICAL 600-PATIENT STUDIES TO ASSESS EFFICACY,SAFETY.APELLIS PHARMACEUTICALS INC - PHASE 3 TRIALS EVALUATING APL-2 WILL BE SUBSTANTIALLY SIMILAR IN DESIGN TO APELLIS' ONGOING PHASE 2 FILLY TRIAL.  Full Article

Cormorant Asset Management LLC reports 7.05 percent passive stake in Apellis Pharmaceuticals Inc
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Apellis Pharmaceuticals Inc :Cormorant Asset Management LLC reports 7.05 percent passive stake in Apellis Pharmaceuticals Inc ‍​as of November 13 - SEC filing.  Full Article

Apellis Pharmaceuticals announces closing of its IPO
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Apellis Pharmaceuticals Inc ::Apellis pharmaceuticals announces closing of its initial public offering.  Full Article

Apellis Pharma shares debut about 3.6 pct above IPO price
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - :Apellis Pharmaceuticals Inc shares open at $14.50 in debut on the NASDAQ versus IPO price of $14 per share‍​.  Full Article

Apellis prices IPO of 10.7 mln common shares at $14/shr
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Apellis Pharmaceuticals Inc :Apellis Pharmaceuticals announces pricing of initial public offering.Says initial public offering of 10.7 million common shares priced at $14.00 per share.  Full Article

Apellis Pharmaceuticals sees IPO of 10.71 mln shares‍​ of common stock
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Apellis Pharmaceuticals Inc :Apellis Pharmaceuticals Inc sees IPO of 10.71 million shares‍​ of common stock to be priced between $13.00 and $15.00 per share - sec filing.  Full Article

Apellis Pharma adds Evercore ISI as IPO underwriter
Friday, 20 Oct 2017 

Oct 20 (Reuters) - Apellis Pharmaceuticals Inc :Apellis Pharmaceuticals Inc says it adds Evercore ISI to underwriters to the IPO - SEC filing‍​.  Full Article

BRIEF-Apellis Finalizes Late Stage Trial Plans For Eye Disease Treatment

* APELLIS FINALIZES PHASE 3 CLINICAL TRIAL PLANS FOR GEOGRAPHIC ATROPHY TREATMENT WITH APL-2